Publications by authors named "T ORLOWSKI"

Article Synopsis
  • The POL-MOL study aimed to assess the use of molecular testing in Polish patients diagnosed with metastatic non-small cell lung cancer (NSCLC), as its extent was previously unknown.
  • Oncologists completed questionnaires about molecular testing for various genetic mutations and PD-L1 assessment, collecting data from 1001 patients receiving systemic treatment.
  • Results indicated that molecular tests were conducted in 78% of NSCLC patients, with higher testing rates in more advanced disease stages, and about 30% of tests in squamous cell carcinoma patients were positive for specific mutations.
View Article and Find Full Text PDF

The emergence of targeted therapies in non-small-cell lung cancer (NSCLC), including inhibitors of epidermal growth factor receptor (EGFR) tyrosine kinase, has increased the need for robust companion diagnostic tests. Nowadays, detection of actionable variants in exons 18-21 of the gene by qPCR and direct DNA sequencing is often replaced by next-generation sequencing (NGS). In this study, we evaluated the diagnostic usefulness of targeted NGS for druggable variants testing in clinical NSCLC material previously analyzed by the IVD-certified qPCR test with respect to DNA reference material.

View Article and Find Full Text PDF

Background And Objective: Pulmonary vascular variations are a major factor in thoracic surgeries. Minimally invasive techniques, such as video-assisted thoracic surgery (VATS) used in non-small lung cancer treatment, have a limited field of view and no haptic feedback. Additionally, new studies suggest that segmentectomies are beneficial for patients.

View Article and Find Full Text PDF

Background: The theoretical advantage of academic hospitals over nonacademic are: more qualified surgeons, adequate diagnostic facilities and infrastructure, including intensive care units. The aim of the study was to compare the effectiveness of surgical lung cancer treatment in academic (ACA) and nonacademic (non-ACA) centers.

Methods: This was a retrospective analysis of data from 31,777 patients surgically-treated for lung cancer during the period from 2007 to 2020 in 9 ACA and 21 non-ACA centers.

View Article and Find Full Text PDF